T. Meeker

Treatment of lupus‐prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms

R. Coffman, C. Guiducci, F. Barrat, 2007, European journal of immunology.

Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus

S. Akira, R. Coffman, S. Uematsu, 2005, The Journal of experimental medicine.

TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus

V. Pascual, J. Banchereau, D. Chaussabel, 2010, Nature.

The metal-binding domain of IGFBP-3 selectively delivers therapeutic molecules into cancer cells

Baljit Singh, D. Mascarenhas, T. Meeker, 2009, Anti-cancer drugs.

Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus

S. Akira, R. Coffman, S. Uematsu, 2005, The Journal of experimental medicine.